Jonathan Sheena - Mar 17, 2025 Form 4 Insider Report for Natera, Inc. (NTRA)

Signature
/s/ Tami Chen, Attorney-in-Fact
Stock symbol
NTRA
Transactions as of
Mar 17, 2025
Transactions value $
-$856,410
Form type
4
Date filed
3/19/2025, 09:35 PM
Previous filing
Mar 14, 2025
Next filing
Apr 4, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NTRA Common Stock Sale -$26.4K -181 -0.07% $146.03 261K Mar 17, 2025 Direct F1
transaction NTRA Common Stock Sale -$293K -2.02K -0.77% $145.17 259K Mar 18, 2025 Direct F2, F3
transaction NTRA Common Stock Sale -$7.72K -53 -0.02% $145.60 259K Mar 18, 2025 Direct F2
transaction NTRA Common Stock Sale -$92.5K -630 -0.24% $146.81 258K Mar 18, 2025 Direct F2, F4
transaction NTRA Common Stock Sale -$155K -1.07K -2.47% $145.09 42.2K Mar 18, 2025 By Caraluna 1 Trust F5, F6, F7
transaction NTRA Common Stock Sale -$63.1K -430 -1.02% $146.78 41.8K Mar 18, 2025 By Caraluna 1 Trust F5, F7, F8
transaction NTRA Common Stock Sale -$147K -1.01K -2.33% $145.21 42.3K Mar 18, 2025 By Caraluna 2 Trust F5, F7, F9
transaction NTRA Common Stock Sale -$71.9K -490 -1.16% $146.78 41.8K Mar 18, 2025 By Caraluna 2 Trust F5, F7, F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on March 12, 2025.
F2 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023.
F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.55 to $145.49 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.78 to $147.01 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 7, 2024.
F6 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.55 to $145.43 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F7 Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
F8 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.78 to $146.79 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F9 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.67 to $145.49 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F10 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.40 to $146.96 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.